Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$18.57

0.89 (5.03%)

12:07
10/03/16
10/03
12:07
10/03/16
12:07

Exact Sciences rises after NCQA updates colorectal cancer screening measure

The National Committee for Quality Assurance, or NCQA, announced that it has updated the HEDIS Colorectal Cancer Screening measure in order to respond to recently revised scientific guidelines by the US Preventive Services Task Force. The USPSTF recommends colorectal cancer screening that includes a variety of tests, and noted that offering more options and sharing decision making with patients may be an opportunity to improve screening rates. Colorectal Cancer Screening is a long-standing, widely used measure. Changes to the measure align with USPSTF recommendations, and will be published in the October Technical Specifications Update. The updated measure is effective for HEDIS 2017. Shares of Exact Sciences, which markets a non invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer, are higher in afternoon trading after the NCQA's announcement of its update.

  • 04

    Oct

  • 26

    Oct

  • 15

    Nov

EXAS Exact Sciences
$18.57

0.89 (5.03%)

08/10/16
BARD
08/10/16
NO CHANGE
BARD
Outperform
HCSC coverage of Cologuard could pressure other payors, says Baird
Baird analyst Catherine Ramsey noted that Health Care Service Corporation, or HCSC, which is the nation's largest customer-owned health insurance company as the owner of several Blue Cross and Blue Shield systems, has posted a pending medical policy that would provide coverage for Exact Sciences' Cologuard. Coverage of the test by HCSC would be a "significant win" and could help pressure other payors to update their policies, said Ramsey, who keeps an Outperform rating on Exact Sciences shares.
08/10/16
CHLM
08/10/16
NO CHANGE
Target $26
CHLM
Buy
Craig-Hallum positive on HCSC, Florida Blue coverage of Exact Sciences Cologuard
Craig-Hallum analyst Bill Bonello notes that two payors, namely Health Care Service Corporation, or HCSC, and Florida Blue posted updated Medical Policies indicating that Exact Sciences' Cologuard may be "medically necessary" for colorectal cancer screening. The analyst believes this is a "very positive" indicator of how other payors will interpret the positive recommendation from the U.S. Preventive Services Task Force issued in June. Further, he sees Exact Sciences as well positioned to become standard of care for colon cancer screening, which could be a $3B-$5B opportunity over time. Bonello reiterates a Buy rating and $26 price target on the shares.
08/15/16
ADAM
08/15/16
NO CHANGE
Target $24
ADAM
Buy
Exact Sciences price target raised to $24 from $19 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Exact Sciences to $24 from $19 citing expectations of ongoing commercial momentum in the second half of the year coupled with new commercial payor wins. Massaro raised its numbers based on recent payor wins and the belief Q3 guidance feels achievable. Massaro reiterated his Buy rating on Exact Sciences shares.
09/01/16
CHLM
09/01/16
NO CHANGE
Target $26
CHLM
Buy
Exact Sciences Cologuard to receive commercial payor coverage, says Craig-Hallum
After eviCore suggested that Exact Sciences' Cologuard may be considered for colorectal cancer screening once every three years, Craig-Hallum analyst Bill Bonello says he believes that at least one large health insurer, Highmark, has already elected to follow this policy. The analyst continues to believe that Cologuard will receive broad commercial payer coverage in light of the 2016 USPSFT final colorectal cancer screening recommendation and that increased payer coverage will drive increased test volumes. He reiterates a Buy rating and $26 price target on the shares.

TODAY'S FREE FLY STORIES

FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

, DDAIF

Daimler AG

$90.25

1.44 (1.62%)

06:41
01/16/18
01/16
06:41
01/16/18
06:41
Periodicals
Fiat Chrysler, Daimler warn over Europe's emissions targets, FT says »

Fiat Chrysler (FCAU) and…

FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

DDAIF

Daimler AG

$90.25

1.44 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAC

GAP Airports

$102.12

0.45 (0.44%)

06:39
01/16/18
01/16
06:39
01/16/18
06:39
Earnings
GAP Airports sees FY18 total revenue growth 13%, plus or minus 1% »

FY18 revenue consensus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.76

-0.26 (-1.37%)

06:39
01/16/18
01/16
06:39
01/16/18
06:39
Hot Stocks
GE Capital to fund contributions, suspend dividend to GE for forseeable future »

GE Capital to fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

GE

General Electric

$18.76

-0.26 (-1.37%)

06:39
01/16/18
01/16
06:39
01/16/18
06:39
Hot Stocks
GE to take $6.2B charge in Q4 on insurance operations »

GE announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

K

Kellogg

$64.69

-1.29 (-1.96%)

, CPB

Campbell Soup

$45.51

-0.24 (-0.52%)

06:39
01/16/18
01/16
06:39
01/16/18
06:39
Recommendations
Kellogg, Campbell Soup analyst commentary  »

Kellogg added to U.S.…

K

Kellogg

$64.69

-1.29 (-1.96%)

CPB

Campbell Soup

$45.51

-0.24 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

CPB

Campbell Soup

$45.51

-0.24 (-0.52%)

06:37
01/16/18
01/16
06:37
01/16/18
06:37
Upgrade
Campbell Soup rating change  »

Campbell Soup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$24.01

0.63 (2.69%)

06:36
01/16/18
01/16
06:36
01/16/18
06:36
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$126.96

1.52 (1.21%)

06:35
01/16/18
01/16
06:35
01/16/18
06:35
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$27.53

0.38 (1.40%)

06:34
01/16/18
01/16
06:34
01/16/18
06:34
Periodicals
Airbus prepared to shut down production of A380 superjumbo, FT reports »

Airbus is ready to shut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$34.63

2.54 (7.92%)

06:34
01/16/18
01/16
06:34
01/16/18
06:34
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$18.81

1.47 (8.48%)

06:33
01/16/18
01/16
06:33
01/16/18
06:33
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$36.73

0.53 (1.46%)

06:32
01/16/18
01/16
06:32
01/16/18
06:32
Upgrade
21st Century Fox rating change  »

21st Century Fox upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

DUST

Direxion Daily Gold Miners Bear 3X ETF

$21.30

-1.89 (-8.15%)

06:32
01/16/18
01/16
06:32
01/16/18
06:32
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SP

SP Plus Corp.

$38.00

0.2 (0.53%)

06:31
01/16/18
01/16
06:31
01/16/18
06:31
Hot Stocks
SP Plus Corp. sells joint venture interest in Parkmobile, sees Q1 gain »

SP Plus Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$47.10

-4.42 (-8.58%)

06:31
01/16/18
01/16
06:31
01/16/18
06:31
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$25.85

0.01 (0.04%)

06:30
01/16/18
01/16
06:30
01/16/18
06:30
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLB

Dolby

$65.35

1.06 (1.65%)

06:29
01/16/18
01/16
06:29
01/16/18
06:29
Downgrade
Dolby rating change  »

Dolby downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$144.75

-0.25 (-0.17%)

06:29
01/16/18
01/16
06:29
01/16/18
06:29
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$76.84

1.28 (1.69%)

06:28
01/16/18
01/16
06:28
01/16/18
06:28
Periodicals
Citi results likely 'overwhelmed' by $20B charge due to tax overhaul, WSJ says »

Citigroup's results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

JPM

JPMorgan

$112.67

1.83 (1.65%)

06:28
01/16/18
01/16
06:28
01/16/18
06:28
Hot Stocks
JPMorgan reports December net credit losses 2.43% vs. 2.36% last month »

Reports December 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$4.74

0.01 (0.21%)

06:27
01/16/18
01/16
06:27
01/16/18
06:27
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INNV

Innovus Pharmaceuticals

06:27
01/16/18
01/16
06:27
01/16/18
06:27
Hot Stocks
Innovus Pharmaceuticals' hemorrhoid drug Xyralid approved in Canada »

Innovus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$138.19

-0.02 (-0.01%)

06:26
01/16/18
01/16
06:26
01/16/18
06:26
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$187.95

0.06 (0.03%)

06:25
01/16/18
01/16
06:25
01/16/18
06:25
Recommendations
Tyler Technologies analyst commentary  »

Tyler Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 26

    Feb

FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

06:25
01/16/18
01/16
06:25
01/16/18
06:25
Periodicals
Fiat Chrysler's Marchionne says new CEO to be named this year, AP reports »

Fiat Chrysler CEO Sergio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.